Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:50:48 +0200Mon, 13 May 2024 16:50:00 +0200Onglyza : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-1039-en.pdfOnglyza : EPAR - Product Informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-1039-en.pdfMon, 13 May 2024 16:50:00 +0200Human medicineHuman medicines European public assessment report (EPAR): Onglyza, saxagliptin, Date of authorisation: 30/09/2009, Revision: 23, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/onglyzaHuman medicines European public assessment report (EPAR): Onglyza, saxagliptin, Date of authorisation: 30/09/2009, Revision: 23, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/onglyzaMon, 13 May 2024 15:14:00 +0200Human medicine